Prenumeration
On 16 June 2025, Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced that the Company had entered into a conditional agreement to acquire Pharmacure Healthcare International AB (“Pharmacure”). In addition, Nosa Plugs completed a directed share issue of approximately SEK 34.6m and announced updated financial targets. The acquisition of Pharmacure is conditional upon, among other things, an approved FDI application and is expected to be completed no later than Q3-25.
Read Analyst Group’s comment here
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.